- Home
- ARCT vs NCV Comparison
ARCT vs NCV Comparison
Compare ARCT & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- NCV
- Stock Information
- Founded
- ARCT 2013
- NCV 2003
- Country
- ARCT United States
- NCV United States
- Employees
- ARCT N/A
- NCV N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- NCV Finance Companies
- Sector
- ARCT Health Care
- NCV Finance
- Exchange
- ARCT Nasdaq
- NCV Nasdaq
- Market Cap
- ARCT 298.3M
- NCV 305.7M
- IPO Year
- ARCT N/A
- NCV N/A
- Fundamental
- Price
- ARCT $11.89
- NCV $13.60
- Analyst Decision
- ARCT Strong Buy
- NCV
- Analyst Count
- ARCT 8
- NCV 0
- Target Price
- ARCT $52.33
- NCV N/A
- AVG Volume (30 Days)
- ARCT 484.3K
- NCV 405.1K
- Earning Date
- ARCT 08-04-2025
- NCV 01-01-0001
- Dividend Yield
- ARCT N/A
- NCV 12.48%
- EPS Growth
- ARCT N/A
- NCV N/A
- EPS
- ARCT N/A
- NCV N/A
- Revenue
- ARCT $143,680,000.00
- NCV N/A
- Revenue This Year
- ARCT N/A
- NCV N/A
- Revenue Next Year
- ARCT $39.32
- NCV N/A
- P/E Ratio
- ARCT N/A
- NCV N/A
- Revenue Growth
- ARCT 15.38
- NCV N/A
- 52 Week Low
- ARCT $8.04
- NCV $2.84
- 52 Week High
- ARCT $45.00
- NCV $3.59
- Technical
- Relative Strength Index (RSI)
- ARCT 48.75
- NCV 63.97
- Support Level
- ARCT $11.51
- NCV $13.36
- Resistance Level
- ARCT $13.27
- NCV $13.56
- Average True Range (ATR)
- ARCT 0.82
- NCV 0.18
- MACD
- ARCT 0.01
- NCV 0.00
- Stochastic Oscillator
- ARCT 26.15
- NCV 90.63
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.